Correlation Between Vivos Therapeutics and Heartbeam Warrant

Can any of the company-specific risk be diversified away by investing in both Vivos Therapeutics and Heartbeam Warrant at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivos Therapeutics and Heartbeam Warrant into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vivos Therapeutics and Heartbeam Warrant, you can compare the effects of market volatilities on Vivos Therapeutics and Heartbeam Warrant and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivos Therapeutics with a short position of Heartbeam Warrant. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivos Therapeutics and Heartbeam Warrant.

Diversification Opportunities for Vivos Therapeutics and Heartbeam Warrant

0.63

Correlation Coefficient

Vivos Therapeutics  Heartbeam Warrant

Poor diversification

The 3 months correlation between Vivos and Heartbeam is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Vivos Therapeutics and Heartbeam Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heartbeam Warrant and Vivos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivos Therapeutics are associated (or correlated) with Heartbeam Warrant. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heartbeam Warrant has no effect on the direction of Vivos Therapeutics i.e., Vivos Therapeutics and Heartbeam Warrant go up and down completely randomly.

Pair Corralation between Vivos Therapeutics and Heartbeam Warrant

Given the investment horizon of 90 days Vivos Therapeutics is expected to generate 1.33 times less return on investment than Heartbeam Warrant. But when comparing it to its historical volatility, Vivos Therapeutics is 1.59 times less risky than Heartbeam Warrant. It trades about 0.17 of its potential returns per unit of risk. Heartbeam Warrant is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  50.00  in Heartbeam Warrant on September 20, 2024 and sell it today you would earn a total of  32.00  from holding Heartbeam Warrant or generate 64.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	92.06%
Values	Daily Returns

Vivos Therapeutics  vs.  Heartbeam Warrant

Vivos Therapeutics

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Heartbeam Warrant

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Heartbeam Warrant are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Heartbeam Warrant showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Vivos Therapeutics and Heartbeam Warrant

The main advantage of trading using opposite Vivos Therapeutics and Heartbeam Warrant positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivos Therapeutics position performs unexpectedly, Heartbeam Warrant can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heartbeam Warrant will offset losses from the drop in Heartbeam Warrant's long position.

The idea behind Vivos Therapeutics and Heartbeam Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.